the results with this inhibitor in melanoma, gleevec-like results. there's 10, 15% of lung cancer patients who are just starting to see that we're turning the tied against cancer with this new paradigm. we're moving from an era of non-specific chemotherapy to very prehe'sly targeted drugs that are more effective and less toxic. >> charlie: that's the story. >> that's the real story on gleevec. >> charlie: what's the big unanswered question about cancer? >> one is why do cells get it in the first place. why do i get a mutation and you not. we know -- >> charlie: what are possible answers for that. >> we know that certain environmental exposures, smoking, obviously, exposure to chemotherapy for breast cancer can cause a patient to get leukemia later. damaging the dna in blood cells. but we don't know why most measures don't have these exposures. it could be just aging. cells as they divide and get older, it happens in copying the dna and mutation is created. if it's in the wrong cell that's probably what happens. >> charlie: go ahead. >> now charlie's